Predictive factors for blood stream infections in children with cancer

Pediatric Hematology and Oncology

Volumn 30, Issue 5, 2013, Pages 403-415

  Doganis, Dimitrios ^a,b   Asmar, Basim ^c   Yankelevich, Maxim ^a   Thomas, Ronald ^d   Ravindranath, Yaddanapudi ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

Blood stream infection; Cancer; Children

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; COTRIMOXAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; PENTAMIDINE; STEROID;

ADOLESCENT; AFRICAN AMERICAN; ANTIBIOTIC THERAPY; ARTICLE; ASIAN; BLOOD CULTURE; BLOODSTREAM INFECTION; CANCER CHEMOTHERAPY; CANDIDIASIS; CAUCASIAN; CHILD; CHILDHOOD CANCER; CHILDHOOD DISEASE; CHILL; CONFUSION; DIZZINESS; ERYTHROCYTE TRANSFUSION; FEMALE; HISPANIC; HUMAN; HYPOTENSION; LETHARGY; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RACE; RETROSPECTIVE STUDY; SCHOOL CHILD; SOLID TUMOR; SOMNOLENCE; STAPHYLOCOCCUS INFECTION; STEM CELL TRANSPLANTATION; TEMPERATURE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD-BORNE PATHOGENS; CHILD; CROSS INFECTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84880394208     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2013.778379     Document Type: Article

References (35)

1. Viscoli C, Castagnola E, Giacchino M, et al. Bloodstream infections in children with cancer: A multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section. Eur J Cancer. 1999;35:770-774
2. Paganini HR, Aguirre C, Puppa G, et al. Febrile Neutropenia Study Group. A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer. Cancer. 2007;109:2572-2579
3. Basu SK, Fernandez ID, Fisher SG, et al. Length of stay and mortality associated with febrile neutropenia among children with cancer. J Clin Oncol. 2005;23:7958-7966
4. Lowis SP, Goulden N, Oakhill A. Acute complications. Infection. In: Pinkerton R, Plowman PN, Pieters R, eds. Paediatric Oncology. 3rd ed. London: Hodder Arnold Publication; 2004:635-638
5. Pizzo PA.Management of fever in patients with cancer and treatment-induced neutropenia.N Engl J Med. 1993;328:1323-1332
6. Biwersi C, Hepping N, Bode U, et al. Bloodstream infections in a German paediatric oncology unit: Prolongation of inpatient treatment and additional costs. Int J HygEnviron Health. 2009;212:541-546
7. Sakaguchi S, SaitoM, Tsuji H, et al. Bacterial rRNA-Targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia. J ClinMicrobiol. 2010;48:1624-1628
8. Beekmann SE, Diekema DJ, Chapin KC, Doern GV. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J ClinMicrobiol. 2003;41:3119-3125
9. Dean PP, Dark P. The diagnostic future for bloodstream infections? Intensive Care Med. 2011;37:355-356
10. Rondinelli PI, Ribeiro Kde C, de Camargo B. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol. 2006;28:665-670
11. Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia and fever. J Clin Oncol. 2001;19:3415-3421
12. Ammann RA, Hirt A, Lüthy AR, Aebi C. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol. 2003;41:436-443
13. Santolaya ME, Alvarez AM, Aviĺes CL, et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis. 2002;35:678-683
14. Klaassen RJ, Goodman TR, Pham B, Doyle JJ. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18:1012-1019
15. Macher E, Dubos F, Garnier N, et al. Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia. Pediatr Blood Cancer. 2010;55:662-667
16. Baorto EP, Aquino VM,Mullen CA, et al. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer. 2001;92:909-913
17. Asturias EJ, Corral JE, Quezada J. Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia. Curr Oncol. 2010;17:59-63
18. Ammann RA, Hirt A, Lüthy AR, Aebi C. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J. 2004;23:61-67
19. SpasovaMI, Grudeva-Popova JG, Kostyanev SS, et al. Risk index score for bacteremia in febrile neutropenic episodes in children withmalignancies. J BUON. 2009;14:411-418
20. Aquino VM, Tkaezewski Y, BuchananG. Early discharge of low-risk febrile neutropenic children and adolescents with cancer. Clin Infect Dis. 1997;25:74-78
21. Aquino VM, Buchanan GR, Tkaczewsky Y, et al. Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia. Med Pediatr Oncol. 1997;28:191-195
22. Alexander SW,Walsh TJ, Freifeld AG, Pizzo PA. Infectious complications in pediatric cancer patients. In: PizzoPA, PoplackDG, eds. Principles and Practice of Pediatric Oncology. 4th ed. Philadelphia, PA: LippincottWilliams & Wilkins, 2002:1239-1283
23. Klastersky J, Paesmans M, Rubenstein EB, et al. The multinational association for supportive care in cancer risk index: A multinational scoring system for identifying low-risk. J Clin Oncol. 2000;18:3038-3051
24. Alexander SW,Wade KC, Hibberd PL, Parsons SK. Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2002;24:38-42
25. Hann I, Viscoli C, Paesmans M, et al. A comparison of outcome fromfebrile neutropenic episodes in children compared with adults: Results from four EORTC studies, International Antimicrobial Therapy Cooperative Group (IATCG) of the European Or. of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol. 1997;99:580-588
26. Lai HP, Hsueh PR, Chen YC, et al. Bacteremia in hematological and oncological children with febrile neutropenia: Experience in a tertiary medical center in Taiwan. J Microbiol Immunol Infect. 2003;36:197-202
27. Lucas KG, Brown AE, ArmstrongD, et al.Theidentification of febrile, neutropenic childrenwith neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer. 1996;77:791-798
28. Madsen K, Rosenman M, Hui S, Breitfeld PP. Value of electronic data for model validation and refinement: Bacteremia risk in children with fever and neutropenia. J Pediatr Hematol Oncol. 2002;24:256-262
29. Rackoff WR, Gonin R, Robinson C, et al. Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol. 1996;14:919-924
30. Kelly MJ, Vivier PM, Panken TM, Schwartz CL. Bacteremia in febrile nonneutropenic pediatric oncology patients. Pediatr Blood Cancer. 2010;54:83-87
31. Pizzo PA, Robichaud KJ,Wesley R, Commers Jr. Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine (Baltimore). 1982;61:153-165
32. Scheinemann K, Ethier MC, Dupuis LL, et al. Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line. Support Care Cancer. 2010;18:913-919
33. Richardson MW, Grewal SS, Visintainer PF. Emesis predicts bacteremia in immunocompromised children with central venous catheters and fever. Cancer. 2009;115:3335-3340
34. Allen RC,Holdsworth MT, Johnson CA, et al. Risk determinants for catheter-Associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer. 2008;51:53-58
35. Hakim H, Flynn PM, Srivastava DK, et al. Risk prediction in pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J. 2010;29:53-59